Cargando…
Targeting adaptor protein SLP76 of RAGE as a therapeutic approach for lethal sepsis
Accumulating evidence shows that RAGE has an important function in the pathogenesis of sepsis. However, the mechanisms by which RAGE transduces signals to downstream kinase cascades during septic shock are not clear. Here, we identify SLP76 as a binding partner for the cytosolic tail of RAGE both in...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804203/ https://www.ncbi.nlm.nih.gov/pubmed/33436632 http://dx.doi.org/10.1038/s41467-020-20577-3 |
_version_ | 1783636110225702912 |
---|---|
author | Yan, Zhengzheng Luo, Haihua Xie, Bingyao Tian, Tian Li, Shan Chen, Zhixia Liu, Jinghua Zhao, Xuwen Zhang, Liyong Deng, Yongqiang Billiar, Timothy R. Jiang, Yong |
author_facet | Yan, Zhengzheng Luo, Haihua Xie, Bingyao Tian, Tian Li, Shan Chen, Zhixia Liu, Jinghua Zhao, Xuwen Zhang, Liyong Deng, Yongqiang Billiar, Timothy R. Jiang, Yong |
author_sort | Yan, Zhengzheng |
collection | PubMed |
description | Accumulating evidence shows that RAGE has an important function in the pathogenesis of sepsis. However, the mechanisms by which RAGE transduces signals to downstream kinase cascades during septic shock are not clear. Here, we identify SLP76 as a binding partner for the cytosolic tail of RAGE both in vitro and in vivo and demonstrate that SLP76 binds RAGE through its sterile α motif (SAM) to mediate downstream signaling. Genetic deficiency of RAGE or SLP76 reduces AGE-induced phosphorylation of p38 MAPK, ERK1/2 and IKKα/β, as well as cytokine release. Delivery of the SAM domain into macrophages via the TAT cell-penetrating peptide blocks proinflammatory cytokine production. Furthermore, administration of TAT-SAM attenuates inflammatory cytokine release and tissue damage in mice subjected to cecal ligation and puncture (CLP) and protects these mice from the lethality of sepsis. These findings reveal an important function for SLP76 in RAGE-mediated pro-inflammatory signaling and shed light on the development of SLP76-targeted therapeutics for sepsis. |
format | Online Article Text |
id | pubmed-7804203 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-78042032021-01-21 Targeting adaptor protein SLP76 of RAGE as a therapeutic approach for lethal sepsis Yan, Zhengzheng Luo, Haihua Xie, Bingyao Tian, Tian Li, Shan Chen, Zhixia Liu, Jinghua Zhao, Xuwen Zhang, Liyong Deng, Yongqiang Billiar, Timothy R. Jiang, Yong Nat Commun Article Accumulating evidence shows that RAGE has an important function in the pathogenesis of sepsis. However, the mechanisms by which RAGE transduces signals to downstream kinase cascades during septic shock are not clear. Here, we identify SLP76 as a binding partner for the cytosolic tail of RAGE both in vitro and in vivo and demonstrate that SLP76 binds RAGE through its sterile α motif (SAM) to mediate downstream signaling. Genetic deficiency of RAGE or SLP76 reduces AGE-induced phosphorylation of p38 MAPK, ERK1/2 and IKKα/β, as well as cytokine release. Delivery of the SAM domain into macrophages via the TAT cell-penetrating peptide blocks proinflammatory cytokine production. Furthermore, administration of TAT-SAM attenuates inflammatory cytokine release and tissue damage in mice subjected to cecal ligation and puncture (CLP) and protects these mice from the lethality of sepsis. These findings reveal an important function for SLP76 in RAGE-mediated pro-inflammatory signaling and shed light on the development of SLP76-targeted therapeutics for sepsis. Nature Publishing Group UK 2021-01-12 /pmc/articles/PMC7804203/ /pubmed/33436632 http://dx.doi.org/10.1038/s41467-020-20577-3 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Yan, Zhengzheng Luo, Haihua Xie, Bingyao Tian, Tian Li, Shan Chen, Zhixia Liu, Jinghua Zhao, Xuwen Zhang, Liyong Deng, Yongqiang Billiar, Timothy R. Jiang, Yong Targeting adaptor protein SLP76 of RAGE as a therapeutic approach for lethal sepsis |
title | Targeting adaptor protein SLP76 of RAGE as a therapeutic approach for lethal sepsis |
title_full | Targeting adaptor protein SLP76 of RAGE as a therapeutic approach for lethal sepsis |
title_fullStr | Targeting adaptor protein SLP76 of RAGE as a therapeutic approach for lethal sepsis |
title_full_unstemmed | Targeting adaptor protein SLP76 of RAGE as a therapeutic approach for lethal sepsis |
title_short | Targeting adaptor protein SLP76 of RAGE as a therapeutic approach for lethal sepsis |
title_sort | targeting adaptor protein slp76 of rage as a therapeutic approach for lethal sepsis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804203/ https://www.ncbi.nlm.nih.gov/pubmed/33436632 http://dx.doi.org/10.1038/s41467-020-20577-3 |
work_keys_str_mv | AT yanzhengzheng targetingadaptorproteinslp76ofrageasatherapeuticapproachforlethalsepsis AT luohaihua targetingadaptorproteinslp76ofrageasatherapeuticapproachforlethalsepsis AT xiebingyao targetingadaptorproteinslp76ofrageasatherapeuticapproachforlethalsepsis AT tiantian targetingadaptorproteinslp76ofrageasatherapeuticapproachforlethalsepsis AT lishan targetingadaptorproteinslp76ofrageasatherapeuticapproachforlethalsepsis AT chenzhixia targetingadaptorproteinslp76ofrageasatherapeuticapproachforlethalsepsis AT liujinghua targetingadaptorproteinslp76ofrageasatherapeuticapproachforlethalsepsis AT zhaoxuwen targetingadaptorproteinslp76ofrageasatherapeuticapproachforlethalsepsis AT zhangliyong targetingadaptorproteinslp76ofrageasatherapeuticapproachforlethalsepsis AT dengyongqiang targetingadaptorproteinslp76ofrageasatherapeuticapproachforlethalsepsis AT billiartimothyr targetingadaptorproteinslp76ofrageasatherapeuticapproachforlethalsepsis AT jiangyong targetingadaptorproteinslp76ofrageasatherapeuticapproachforlethalsepsis |